Lifecore Biomedical (LFCR) has released an update.
Lifecore Biomedical, Inc. is on the brink of being delisted from Nasdaq due to non-compliance with filing requirements for periodic financial reports. Nasdaq’s notification kick-started a delisting procedure, but the company is appealing this decision and is working to resolve the issue by completing necessary restatements and filings. They have also requested a hearing to delay any suspension or delisting action, but there is uncertainty whether they can regain compliance in time to avoid delisting.
For further insights into LFCR stock, check out TipRanks’ Stock Analysis page.
